NAD<sup>+</sup> metabolism, stemness, the immune response, and cancer.

Navas LE, Carnero A. · 2021

Read NAD<sup>+</sup> metabolism, stemness, the immune response, and cancer. by Navas LE, Carnero A. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7775471.txt.

Introduction

Navas and Carnero review NAD+ metabolism and its links to cancer. NAD+ is a helper molecule for energy reactions in cells. It also feeds enzymes that repair DNA and tune genes. Its levels fall out of balance in metabolic disease, aging, and cancer. Cells cannot take NAD+ direct from food.

One enzyme, NAMPT, rebuilds most of the cell's NAD+ from a spent form. Tumors lean hard on this supply for growth and stem-like traits. NAD+ also shapes immune responses to cancer. The authors trace these ties through cancer metabolism and aging. They end with therapies that block or boost parts of this network.

Catalog record

CREATORNavas LE, Carnero A.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE156 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7775471

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

NAD+ metabolism, stemness, the immune response, and cancer By Lola E Navas, Amancio Carnero Published in: Signal Transduction and Targeted Therapy DOI: 10.1038/s41392-020-00354-w ABSTRACT Abstract NAD+ was discovered during yeast fermentation, and since its discovery, its important roles in redox metabolism, aging, and longevity, the immune system and DNA repair have been highlighted. A deregulation of the NAD+ levels has been associated with metabolic diseases and aging-related diseases, including neurodegeneration, defective immune responses, and cancer. NAD+ acts as a cofactor through its interplay with NADH, playing an essential role in many enzymatic reactions of energy metabolism, such as glycolysis, oxidative phosphorylation, fatty acid oxidation, and the TCA cycle. NAD+ also plays a role in deacetylation by sirtuins and ADP ribosylation during DNA damage/repair by PARP proteins. Finally, different NAD hydrolase proteins also consume NAD+ while converting it into ADP-ribose or its cyclic counterpart. Some of these proteins, such as CD38, seem to be extensively involved in the immune response. Since NAD cannot be taken directly from food, NAD metabolism is essential, and NAMPT is the key enzyme recovering NAD from nicotinamide and generating most of the NAD cellular pools. Because of the complex network of pathways in which NAD+ is essential, the important role of NAD+ and its key generating enzyme, NAMPT, in cancer is understandable. In the present work, we review the role of NAD+ and NAMPT in the ways that they may influence cancer metabolism, the immune system, stemness, aging, and cancer. Finally, we review some ongoing research on therapeutic approaches. Subject terms: Cancer stem cells, Molecular medicine, Cancer metabolism, Cancer therapy INTRODUCTION Nicotinamide adenine dinucleotide (NAD+) is an abundant metabolite that plays an essential role in the maintenance of cellular homeostasis. NAD+ acts as a cofactor in multiple reduction-oxidation (redox) reactions related to energy production, glycolysis, the tricarboxylic acid (TCA) cycle, oxidative phosphorylation (OXPHOS), fatty acid oxidation (FAO), and serine biosynthesis.1–3 On the other hand, NAD+ is a substrate for different signaling enzymes, such as sirtuins, PARPs, and cADPRSs. In these reactions, NAD+ is degraded and cleaved into ADP ribose and nicotinamide (NAM), which can be recycled. To respond to the high and dynamic NAD+ cellular demand for both redox and nonredox processes, mammalian cells must synthesize NAD+ from different dietary precursors through the de novo pathway and the Preiss–Handler pathway (Fig. 1). Indeed, a chronic dietary deficiency of these precursors leads to pellagra, which is characterized by diarrhea, dermatitis, dementia, neurological damage, and even death. During an investigation into a treatment for pellagra in the 1920s, NAD+ was discovered as an essential metabolite for cells2,4,5 (Fig. 2). Alternatively, cells can be recycled and NAD+ reconstituted from its catabolic products via the salvage pathway, which is the preferential route for cells to replenish NAD pools6–10 (Fig. 3). NAD levels are limiting components, and the availability of NAD is essential for cellular functionality. Therefore, the biosynthesis, subcellular localization, and systemic transport of NAD and its intermediates are key to the regulation of various biological processes with significant impact on cellular and tissue functionality. To date, studies have revealed a complex layer of tissue/organ-specific effects and differential roles for various NAD intermediates. [Figure: a Structure of nicotinamide adenine dinucleotide (NAD+). This molecule is formed by adenosine monophosphate (AMP) linking to nicotinamide mononucleotide (NMN). AMP is formed by adenosine (in green), ribose ring (in blue) whose hydroxyl (marked in red) can be phosphorylated resulting in NADP+, and phosphate group (in orange). NMN is formed by a ribose ring, phosphate group, and nicotinamide (NAM) (in pink) that is responsible for redox NAD+ functions, thus, the atom carbon (marked in red) is capable of accepting a hydride anion (H+, 2e-) leading to the reduced form NADH. In addition to the classical redox functions, NAD+ acts as a substrate of multiples enzymes donating the group adenosine diphosphate ribose (ADP-ribose) and releasing nicotinamide as the catabolic reaction product. b Structure of the different states of NAD+. NAD+ can be phosphorylated to NADP+ by NADK enzyme. Thus, NAD+ and NADP+ can be reduced to NADH or NADPH, respectively. NADH nicotinamide adenine dinucleotide, NAD+ nicotinamide adenine dinucleotide, NADP+ nicotinamide adenine dinucleotide phosphate, NADPH reduced nicotinamide adenine dinucleotide phosphate] [Figure: NAD+ in cancer metabolism. Cancer cells rely on glycolysis (pathway in yellow) than mitochondrial oxidative phosphorylation (OXPHOS) (in black) what is called the Warburg Effect. The pentose phosphate pathway (in purple), serine synthesis (in green), and fatty acid synthesis (in blue) are also upregulated in cancer and depend on glycolysis as the core of cancer metabolism. Glutaminolysis (in red) is also upregulated as the main nitrogen source. All these pathways require the cofactor NAD+/NADH/NADP+/NADPH as essential cofactors to support faster energy production, counteract ROS production, and synthesis building blocks for tumor proliferation. G6PD glucose-6-phosphate dehydrogenase, GSH glutathione, GSSG glutathione disulfide, ROS reactive oxygen species, GAPDH glyceraldehyde 3-phosphate, LDH lactate dehydrogenase, PRPP 5-phosphoribosyl-1-pyrophosphate] [Figure: NAD+ biosynthesis pathways. NAD+ can be synthesized from the different dietary precursors by de novo pathway (from Trp), the Preiss–Handler pathway (from NA), and the nucleoside pathway (from nicotinic NAR or NR). However, the main source of NAD+ is the salvage pathway where the catabolic product (NAM), from NAD+-consumed enzymes (sirtuins, PARPs and cADPRSs), is recycled to reconstitute NAD+] NAD+ CONCENTRATION AND COMPARTMENTALIZATION Although the oxidized form, NAD+, is the most abundant and ubiquitous state in cells, its availability may fluctuate. Indeed, the free NAD+ concentration largely varies depending on several factors, including its subcellular compartment; the cellular type; glucose level, including deprivation; caloric intake and restriction; exercise; age; and circadian cycles. It has been shown that the cytosolic and nuclear NAD+ pool concentrations are quite similar (approximately 100 µM) because these compartments are interconnected. The mitochondrial NAD+ pool, with a higher concentration (~250–500 µM), is an independent source since the mitochondrial membrane is impermeable to NAD+ and NADH. The free NAD+ concentration also depends on the cell type. For example, myocytes have a greater mitochondrial NAD+ pool, whereas hepatocytes and astrocytes have greater cytosolic NAD+ pools.11 In addition, NAD+ concentration may oscillate throughout the day due to circadian regulation. The CLOCK:BMAL1 complex activates the promoter of NAMPT, the critical enzyme of the NAD+ salvage pathway, in a cyclic manner every 24 hours, increasing NAD+ production. In addition, SIRT1, an NAD+-consumed enzyme, counteracts the effect of the circadian complex by deacetylating BMAL1 and the histones in the promoter region of other regulated genes.12–14 NAD+ has a short half-life, ~1 h in mammalian cells,15 and limited ability to diffuse through cell membrane barriers.16 This impermeability ensures rapid local regulation of NAD-dependent physiological processes and extensive compartmentalization of many enzymes involved in the biosynthesis or consumption of NAD+ has also been described. Therefore, the concentration of NAD+ is not uniform within a cell. Most bioenergy- and NAD+-dependent signaling pathways are activated in different subcellular compartments, and locally accessible NAD+ is required for these metabolic processes.17,18 NAD+ has been detected in the nucleus and in almost all cytoplasmic organelles.19–21 The extracellular NAD+ concentration in the blood serum of mammals is maintained at a low level, between 0.1 and 0.5 μM, under physiological conditions.22 However, the extracellular NAD+ level is connected to the intracellular NAD+ pools. Cells, especially cancer cells, release intracellular NAD+ into the culture medium, indicating

Read the complete text